Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer (Nature Reviews Molecular Cell Biology (2008) 9, (759-769) DOI: 10.1038/nrm2514);Ataxia-telangiectasia: From a rare disorder to a paradigm for cell signalling and cancer

Nature Reviews Molecular Cell Biology

Volumn 9, Issue 10, 2008, Pages 759-769

  Lavin, Martin F ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; HISTONE DEACETYLASE INHIBITOR; PROTEIN A;

ATAXIA TELANGIECTASIA; AUTOPHOSPHORYLATION; CANCER RISK; CELL CYCLE; CELL PROTECTION; DEGENERATIVE DISEASE; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; GENE FUNCTION; GENE IDENTIFICATION; GENOMIC INSTABILITY; HUMAN; INSULIN RESISTANCE; LYMPHOCYTE; METABOLIC SYNDROME X; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ATAXIA TELANGIECTASIA;

EID: 52449114574     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2598     Document Type: Erratum

References (123)

1. Boder, E. Ataxia-telangiectasia: an overview. Kroc. Found. Ser. 19,1-63 (1985). An excellent description of the clinical phenotype in A-T particularly for the neurological defects.
2. Syllaba, K. & Henner, K. Contribution a l'independence de l'athetose double idiopathique et congenitale. Atteinte familiale, syndrome dystrophique, signe de reseau vasculaire conjonctival, integrite psychique. Rev. Neurol. 1, 541-562 (1926) (in French).
3. Boder, E. & Sedgwick, R. P. Ataxia-telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection. A preliminary report on 7 children, an autopsy, and a case history. Univ. S. Calif. Med. Bull. 9, 15-28 (1957).
4. Lavin, M. F. & Shiloh, Y. The genetic defect in ataxia- telangiectasia. Annu. Rev. Immunol. 15, 177-202 (1997). A comprehensive early review on A-T and the cloning and characteristics of the ATM gene.
5. Gatti, R. A. et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22-23. Nature 336, 577-580 (1988).
6. Savitsky, K. et al. A single ataxia-telangiectasia gene with a product similar to PI-3 kinase kinase. Science. 268, 1749-1753 (1995). Describes the identification of the ATM gene, which is defective in A-T.
7. Brumbaugh, K. M. et al. The mRNA surveillance protein hSMG-1 functions in genotoxic stress response pathways in mammalian cells. Mol. Cell 14, 585-598 (2004).
8. Yamashita, A. et al. Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay. Genes Dev. 15, 2215-2228 (2001).
9. Banin, S. et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677 (1998).
10. Canman, C. E. et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679 (1998).
11. Khanna K. K. et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nature Genet. 20, 398-400 (1998). References 9-11 identified the first substrate for ATM, p53.
12. Kastan, M. B. et al. A mammalian cell cycle checkpoint pathway utilising p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597 (1992). Description of a radiation-induced pathway that connects p53 with the A-T gene product.
13. Khanna, K. K. & Lavin, M. F. Ionizing radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8, 3307-3312 (1993).
14. Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160-1166 (2007).
15. Linding, R. et al. Systematic discovery of in vivo phosphorylation networks. Cell 129, 1415-1426 (2007).
16. Bosotti, R., Isacchi, A. & Sonnhammer, E. L. FAT: a novel domain in PIK-related kinases. Trends Biochem. Sci. 25, 225-227 (2000).
17. Shafman, T. et al. Interaction between ATM protein and c-Abl in response to DNA damage. Nature 387, 520-523 (1997). ABL kinase is identified as an ATM interacting protein. See also reference 116.
18. Carney, J. P. et al. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 93, 477-486 (1998).
19. Matsuura, S. et al. Positional cloning of the gene for Nijmegen breakage syndrome. Nature Genet. 19, 179-181 (1998).
20. Varon, R. et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93, 467-476 (1998).
21. Stewart, G. S. et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99, 577-587 (1999).
22. Houldsworth, J. & Lavin, M. F. Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res. 8, 3709-3720 (1980). First description of a cell-cycle checkpoint defect (radioresistant DNA synthesis) in A-T cells. See also reference 23.
23. Painter, R. B. & Young, B. R. Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc. Natl Acad. Sci. USA 77, 7315-7317 (1980).
24. Beamish, H. & Lavin, M. F. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65, 175-184 (1994).
25. Scott, D. & Zampetti-Bosseler, F. Cell cycle dependence of mitotic delay in X-irradiated normal and ataxia-telangiectasia fibroblasts. Int. J. Radiat. Biol. 42, 679-683 (1982).
26. Jaspers, N. G. & Bootsma, D. Abnormal levels of UV-induced unscheduled DNA synthesis in ataxia telangiectasia cells after exposure to ionizing radiation. Mutat. Res. 1-2, 439-446 (1982).
27. Lange, E. et al. Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am. J. Hum. Genet. 1, 112-119 (1995).
28. Savitsky, K. et al. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species. Hum. Mol. Genet. 4, 2025-2032 (1995).
29. Uziel, T. et al. Genomic organization of the ATM gene. Genomics 2, 317-320 (1996).
30. Chun, H. H. & Gatti, R. A. Ataxia-telangiectasia, an evolving phenotype. DNA Repair 3, 1187-1196 (2004).
31. Gotoff, S. P., Amirmokri, E. & Liebner, E. J. Ataxia-telangiectasia. Neoplasia, untoward response to X-irradiation, and tuberous sclerosis. Am. J. Dis. Child. 114, 617-625 (1967).
32. Taylor, A. M. et al. Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 4, 427-429 (1975).
33. Chen, P. C., Lavin, M. F., Kidson, C. & Moss, D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature 274, 484-486 (1978).
34. Riballo, E. et al. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to γ-H2AX foci. Mol. Cell 16, 715-724 (2004).
35. Foray, N. et al. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol. 72, 271-283 (1997).
36. Kuhne, M., Rothkamm, K. & Lobrich, M. No dose-dependence of DNA double-strand break misrejoining following alpha-particle irradiation. Int. J. Radiat. Biol. 76, 891-900 (2000).
37. Goodarzi, A. A. et al. ATM signalling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell 31, 167-177 (2008).
38. Berkovich, E., Monnat, R. J., Jr & Kastan, M. B. Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nature Cell Biol. 9, 683-690 (2007). A model system to investigate the series of events associated with ATM activation.
39. Yazdi, P. T. et al. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16, 571-582 (2002).
40. Kitagawa, R., Bakkenist, C. J., McKinnon, P. J. & Kastan, M. B. Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev. 18, 1423-1438 (2004).
41. Lumsden, J. M. et al. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 200, 1111-1121 (2004).
42. Bredemeyer, A. L. et al. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 442, 466-470 (2006).
43. Vecchio, M. S., Olaru, A., Livak, F. & Hodes, R. J. ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor α locus coding end breaks. Proc. Natl Acad. Sci. USA 104, 6323-6328 (2007).
44. Perkins, E. J. et al. Sensing of intermediates V(D)J recombination by ATM. Genes Dev. 16, 159-164 (2002).
45. + thymocytes. Blood 109, 1887-1896 (2007).
46. Lim, D. S. et al. ATM binds to β-adaptin in cytoplasmic vesicles. Proc. Natl Acad. Sci. USA. 95, 10146-10151 (1998).
47. Watters, D. et al. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274, 34277-34282 (1999).
48. Lavin, M. F. et al. in Handbook of Cell Signalling (eds Bradshaw R. A. and Dennis, E. A.) 225-236 (Academic, London, 2003).
49. Yang, D.Q. & Kastan, M. B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nature Cell Biol. 2, 893-898 (2000).
50. Schlach, D. S., McFarlin, D. & Barlow, M. H. An unusual form of diabetes mellitus in ataxia telangiectasia. N. Engl. J. Med. 282, 1396-1402 (1970).
51. Bar, R. S. et al. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N. Engl. J. Med. 298, 1164-1171 (1978).
52. Schneider, J. G. et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell. Metab. 4, 377-389 (2006).
53. Bakkenist, C. J. & Kastan, M. B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506 (2003). A major contribution to understanding the mechanism of ATM activation.
54. Barlow, C. et al. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl Acad. Sci. USA 97, 871-876 (2000).
55. Biton, S. et al. ATM-mediated response to DNA double strand breaks in human neurons derived from stem cells. DNA Repair 6, 128-134 (2006).
56. Dar, I. et al. Analysis of the ataxia telangiectasia mutated-mediated DNA damage response in murine cerebellar neurons. J. Neurosci. 26, 7767-7674 (2006).
57. Taylor, A. M. R., Groom, A. & Byrd, P. J. Ataxia-telangiectasia-like disorder (ATLD) - its clinical presentation and molecular basis. DNA Repair. 3, 1219-1225 (2004).
58. Cimprich, K. A. & Cortez, D. ATR: an essential regulator of genome integrity. Nature Rev. Mol. Cell Biol. 9, 616-627 (2008).
59. Huen, M. S. Y. & Chen, J. The DNA damage response pathways: at the crossroad of protein modifications. Cell Res. 18, 8-16 (2008).
60. You, Z. et al. Rapid activation of ATM on DNA flanking double-strand breaks. Nature Cell Biol. 9, 1311-1318 (2007).
61. de Jager, M. et al. Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol. Cell 8, 1129-1135 (2001).
62. van den Bosch, M., Bree, R. T. & Lowndes, N. F. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 4, 844-849 (2003).
63. Hopfner, K. P., Craig, L., Moncalian, G., Zinkel, R. A. et al. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination repair. Nature 418, 562-566 (2002).
64. Moreno-Herrero, F. et al. Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA. Nature 437, 440-443 (2005).
65. Paull, T. T. & Gellert, M. The 3′ to 5′ exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol. Cell 1, 969-979 (1998).
66. Paull, T. T. & Gellert, M. Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev. 13, 1276-1288 (1999).
67. Mirzoeva, O. K. & Petrini, J. H. DNA replication-dependent nuclear dynamics of the Mre11 complex. Mol. Cancer Res. 1, 207-218 (2003).
68. Uziel, T. et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22, 5612-5621 (2003). Shows the importance of the MRN complex as an upstream activator of ATM.
69. Cerosaletti, K. & Concannon, P. Independent roles for nibrin and Mre11-Rad50 in the activation and function of Atm. J. Biol. Chem. 279, 38813-38819 (2004).
70. Digweed, M., Reis, A. & Sperling, K. Nijmegen breakage syndrome: consequences of defective DNA double strand break repair. Bioessays 21, 649-656 (1999).
71. Falck, J., Coates, J. & Jackson, S. P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434, 605-611 (2005). Describes a role for NBS1 in the recruitment of ATM to sites of DNA damage.
72. Cerosaletti, K., Wright, J. & Concannon, P. Active role for nibrin in the kinetics of ATM activation. Mol. Cell. Biol. 26, 1691-1699 (2005).
73. Kozlov, S. V. et al. Involvement of novel autophosphorylation sites in ATM activation. EMBO J. 25, 3504-3514 (2006).
74. Goodarzi, A. A., et al. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23, 4451-4461 (2004).
75. Shreeram, S. et al. Wip1 phosphatase modulates ATM-dependent signalling pathways. Mol. Cell 23, 757-764 (2006).
76. Ali, A., et al. Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes Dev. 18, 249-254 (2004).
77. Sun, Y. et al. A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. Proc. Natl Acad. Sci. USA 102, 13182-13187 (2005).
78. Sun, Y. et al. DNA damage-induced acetylation of lysine 3016 of ATM activates ATM kinase activity. Mol. Cell. Biol. 27, 8502-8509 (2007).
79. Pellegrini, M. et al. Autophosphorylation at serine 1987 is dispensable for murine Atm activation in vivo. Nature 443, 222-225 (2006). Describes a mouse model that questions the importance of autophosphorylation in ATM activation.
80. Hamer, G. et al. Ataxia telangiectasia mutated expression and activation of the testis. Biol. Reprod. 70, 1206-1212 (2004).
81. Powers, J. T. et al. E2F1 uses the ATM signalling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol. Cancer Res. 2, 203-214 (2004).
82. Kurz, E. U., Douglas, P. & Lees-Miller, S. Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J. Biol. Chem. 279, 53272-53281 (2004).
83. Shiloh, Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 31, 402-410 (2006).
84. Beausoleil, S. A. et al. Large-scale characterisation of HeLa cell nuclear phosphoproteins. Proc. Natl Acad. Sci. USA 101, 12130-12135 (2004).
85. Lukas, C. et al. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J. 23, 2674-2683 (2004).
86. Jacob, N. K., Stout, A. R. & Price, C. M. Modulation of telomere length dynamics by the subtelomeric region of tetrahymena telomeres. Mol. Biol. Cell 15, 3719-3728 (2004).
87. Bassing, C. H. et al. Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114, 359-370 (2003).
88. Celeste, A. et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114, 371-383 (2003).
89. Stucki, M. & Jackson, S. P. MDC1/NFBD1: A key regulator of the DNA damage response in higher eukaryotes. DNA Repair 3, 953-957 (2004).
90. Chapman, J. R. & Jackson, S. P. Phosphodependent interactions between Nbs1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep. 9, 795-801 (2008).
91. Melander, F. et al. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J. Cell Biol. 181, 213-226 (2008).
92. Huen, M. S. et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131, 901-914 (2007).
93. Kolas, N. K. et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640 (2007).
94. Mailand, N. et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900 (2007).
95. Lavin, M. F. ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26, 7749-7758 (2007).
96. Buscemi, G. et al. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell. Biol. 21, 5214-5222 (2001).
97. Nakanishi, K. et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nature Cell Biol. 4, 913-920 (2002).
98. Gatei, M. et al. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278, 14806-14811 (2003).
99. Spycher, C. et al. Constitutive phosphorylation of MDC1 physically links the Mre11-Rad50-Nbs1 complex to damaged chromatin. J. Cell Biol. 181, 227-240 (2008).
100. Lou, Z., et al. MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals. Mol. Cell 21, 187-200 (2006).
101. Lukas, C. et al. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nature Cell Biol. 5, 255-260 (2003). Describes the use of microlasers to determine the order at which DNA-damage response proteins are recruited to chromatin.
102. Bekker-Jensen, S. et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173, 195-206 (2006).
103. Zhao, S. et al. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405, 473-477 (2000).
104. Wu, X. et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature 405, 477-482 (2000).
105. Gatei, M., Young, D., Cerosaletti, K. M., Desai-Mehta, A. et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nature Genet. 25, 115-119 (2000).
106. Lim, D. S. et al. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404, 613-617 (2000).
107. Lee, J. H. et al. Regulation of Mre11/Rad50 by Nbs1: effects on nucleotide-dependent DNA binding and association with ataxia-telangiectasia-like disorder mutant complexes. J. Biol. Chem. 278, 45171-45178 (2003).
108. Falck, J., Petrini, J. H., Williams, B. R., Lukas, J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Genet. 30, 290-294 (2002).
109. Lee, J. H. & Paull, T. T. ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 551-554 (2005).
110. Soutoglou, E. & Misteli, T. Activation of the cellular DNA damage response in the absence of DNA lesions. Science 320, 1507-1510 (2008).
111. Halazonetis, T. D., Gorgoulis, V. G. & Bartek, J. An oncogene-induced DNA damage model for cancer development. Science 319, 1352-1355 (2008).
112. Swift, M., Morrell, D., Massey, R. B. & Chase, C. L. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N. Engl. J. Med. 325, 1831-1836 (1991). First comprehensive report on increased cancer incidence in A-T heterozygotes in particular breast cancers.
113. Renwick, A. et al. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genet. 38, 873-875 (2008).
114. Kim, S. T., Lim, D. S., Canman, C. E. & Kastan, M. B. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274, 37538-37543 (1999).
115. O'Neill, T. et al. Utilisation of oriented peptide libraries to identify substrate motifs selected by ATM. J. Biol. Chem. 275, 22719-22727 (2000).
116. Petersen, R., Kelly D. & Good, R. A. Ataxia-telangiectasia: its association with a defective thymus, immunological deficiency disease and malignancy. Lancet 1, 1189-1193 (1964).
117. Spector, B. D., Filipovich, A. H., Perry, G.S. & Kersey, H. in Ataxia-Telangiectasia (eds Bridges, B. A. & Harnden, D. G.) 103-141 (John Wiley & Sons, 1982).
118. Cornforth, M. N. & Bedford, J. S. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science 1, 1589-1591 (1985). Describes the defective gene in A-T which is localized to chromosome 11q.
119. Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516-519 (1997).
120. Smith, G. C. et al. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl Acad. Sci. USA. 96, 11134-11139 (1999).
121. Chan, D. W. et al. Purification and characterisation of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase. J. Biol. Chem. 275, 7803-7810 (2000).
122. Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637 (2006).
123. Gougoulis, V. G., Vassiliou, L. V., Karakaidos, P., Zacharatos, P. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).